National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 12123 [2011-4943]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 43 / Friday, March 4, 2011 / Notices
jlentini on DSKJ8SOYB1PROD with NOTICES
this collection contact Carla Ausby at
410–786–2153. For all other issues call
410–786–1326.)
2. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Annual State
Report and Annual State Performance
Rankings; Use: Section 6001(f) of the
Deficit Reduction Act (DRA) requires
CMS to contract with a vendor to
conduct a monthly national survey of
retail prescription drug prices and to
report the prices to the States. These
national average prices may be used as
a benchmark by the States for the
management of their prescription drug
programs. The DRA also requires that
the States submit pricing information
for the 50 most widely prescribed drugs
so that the States’ prices can be
compared to the national average prices
obtained from the survey. The States
pricing information will be compared
and the States will be ranked. The Act
also requires that States report their
drug utilization rates for noninnovator
multiple source (generic) drugs, their
payment rates under their State plan,
and their dispensing fees. The template
has been developed to facilitate data
collection; Form Number: CMS–10241
(OMB#: 0938–1041); Frequency: Yearly;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
51; Total Annual Responses: 51; Total
Annual Hours: 765. (For policy
questions regarding this collection
contact Joseph Fine at 410–786–2128.
For all other issues call 410–786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS Web Site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received by the OMB desk officer at
the address below, no later than 5 p.m.
on April 14, 2011.
OMB, Office of Information and
Regulatory Affairs, Attention: CMS
Desk Officer, Fax Number: (202) 395–
6974, E-mail:
OIRA_submission@omb.eop.gov.
VerDate Mar<15>2010
19:16 Mar 03, 2011
Jkt 223001
Dated: February 23, 2011.
Martique Jones,
Director, Regulations Development Group,
Division B, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2011–4577 Filed 3–3–11; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Blood & Marrow Transplant Network Review
Meeting.
Date: March 28–29, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: ‘‘Courtyard’’ Crystal City—Marriott,
2899 Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Keith A. Mintzer, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7186,
Bethesda, MD 20892–7924, 301–435–0280,
mintzerk@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Pediatric Heart Network Clinical Centers.
Date: March 28–29, 2011.
Time: 1 p.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Crystal City, 2799
Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: William J Johnson, PhD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7178, Bethesda, MD 20892–7924, 301–435–
0725, johnsonwj@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Conference Grant Review.
Date: March 29–30, 2011.
Time: 8 a.m. to 1 p.m.
PO 00000
Frm 00111
Fmt 4703
Sfmt 4703
12123
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting)
Contact Person: Dana Phares, PhD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7179, Bethesda, MD 20892–7924, 301–435–
0310, pharesda@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: February 28, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–4943 Filed 3–3–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel;
Clinical Research.
Date: March 22, 2011.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health/NCRR/
OR, Democracy I, 6701 Democracy Blvd.,
1078, Bethesda, MD (Virtual Meeting).
Contact Person: Steven Birken, PhD,
Scientific Review Officer, Office of Review,
National Center for Research Resources,
National Institutes of Health, 6701
Democracy Blvd., 10th FL., Bethesda, MD
20892, (301) 435–1078,
birkens@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 76, Number 43 (Friday, March 4, 2011)]
[Notices]
[Page 12123]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-4943]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Blood & Marrow Transplant Network Review
Meeting.
Date: March 28-29, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: ``Courtyard'' Crystal City--Marriott, 2899 Jefferson
Davis Highway, Arlington, VA 22202.
Contact Person: Keith A. Mintzer, PhD, Scientific Review
Officer, Review Branch/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7186, Bethesda, MD 20892-7924,
301-435-0280, mintzerk@nhlbi.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Pediatric Heart Network Clinical Centers.
Date: March 28-29, 2011.
Time: 1 p.m. to 11 a.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Crystal City, 2799 Jefferson Davis Highway,
Arlington, VA 22202.
Contact Person: William J Johnson, PhD, Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7178, Bethesda, MD
20892-7924, 301-435-0725, johnsonwj@nhlbi.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Conference Grant Review.
Date: March 29-30, 2011.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting)
Contact Person: Dana Phares, PhD, Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7179, Bethesda, MD 20892-7924,
301-435-0310, pharesda@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: February 28, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-4943 Filed 3-3-11; 8:45 am]
BILLING CODE 4140-01-P
